BioMark Diagnostics Inc.
BMKDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,927 | -$1,427 | -$1,842 | -$1,454 |
| Dep. & Amort. | $401 | $393 | $386 | $180 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $367 | $75 | $330 | $0 |
| Change in WC | $5 | -$86 | $138 | $43 |
| Other Non-Cash | $61 | $63 | $74 | $28 |
| Operating Cash Flow | -$1,093 | -$983 | -$914 | -$1,204 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$4 | -$5 | -$59 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4 | -$4 | -$5 | -$59 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$413 | -$407 | -$300 | -$161 |
| Stock Issued | $3,611 | $1,542 | $603 | $897 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $224 | -$63 | $306 | $929 |
| Financing Cash Flow | $3,422 | $1,072 | $609 | $768 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,325 | $85 | -$311 | -$495 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $157 | $72 | $383 | $878 |
| End Cash | $2,482 | $157 | $72 | $383 |
| Free Cash Flow | -$1,097 | -$987 | -$920 | -$1,263 |